The Clorox Company (NYSE:CLX) Shares Sold by Everence Capital Management Inc.

Everence Capital Management Inc. decreased its holdings in The Clorox Company (NYSE:CLX) by 61.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,690 shares of the company’s stock after selling 2,660 shares during the period. Everence Capital Management Inc.’s holdings in Clorox were worth $274,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of CLX. State Street Corp increased its holdings in shares of Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after purchasing an additional 245,525 shares during the last quarter. Mizuho Securities USA LLC raised its holdings in shares of Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares during the period. Geode Capital Management LLC boosted its position in shares of Clorox by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after acquiring an additional 33,970 shares during the last quarter. Stifel Financial Corp grew its holdings in shares of Clorox by 1.7% in the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after purchasing an additional 37,967 shares during the period. Finally, Nuance Investments LLC increased its position in Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CLX has been the topic of several recent analyst reports. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research report on Sunday. DA Davidson lifted their target price on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. JPMorgan Chase & Co. increased their price target on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Finally, Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and boosted their price objective for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $157.46.

Clorox Stock Up 1.4 %

Clorox stock opened at $159.76 on Wednesday. The firm has a market capitalization of $19.78 billion, a P/E ratio of 55.67, a P/E/G ratio of 3.04 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The stock’s fifty day simple moving average is $164.64 and its 200-day simple moving average is $155.33.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the business earned $0.49 EPS. Clorox’s revenue was up 27.0% on a year-over-year basis. As a group, equities analysts expect that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.05%. Clorox’s dividend payout ratio is currently 170.03%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.